Consolidated Portfolio Review Corp’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.7M | Buy |
7,310
+336
| +5% | +$262K | 0.79% | 26 |
|
|
2025
Q1 | $5.76M | Buy |
6,974
+152
| +2% | +$126K | 0.92% | 19 |
|
|
2024
Q4 | $5.27M | Buy |
6,822
+5,751
| +537% | +$4.44M | 0.83% | 21 |
|
|
2024
Q3 | $949K | Sell |
1,071
-4,530
| -81% | -$4.02M | 0.21% | 122 |
|
|
2024
Q2 | $5.07M | Sell |
5,601
-181
| -3% | -$164K | 1.18% | 17 |
|
|
2024
Q1 | $4.5M | Buy |
5,782
+62
| +1% | +$48.2K | 1.18% | 18 |
|
|
2023
Q4 | $3.33M | Buy |
5,720
+28
| +0.5% | +$16.3K | 0.76% | 28 |
|
|
2023
Q3 | $3.06M | Sell |
5,692
-18
| -0.3% | -$9.67K | 0.74% | 24 |
|
|
2023
Q2 | $2.68M | Buy |
5,710
+4,796
| +525% | +$2.25M | 0.64% | 36 |
|
|
2023
Q1 | $314K | Buy |
+914
| New | +$314K | 0.08% | 207 |
|